Literature DB >> 27476061

Fluorescence resonance energy transfer biosensor between upconverting nanoparticles and palladium nanoparticles for ultrasensitive CEA detection.

Hui Li1, Liang Shi2, De-En Sun3, Peiwu Li4, Zhihong Liu5.   

Abstract

An ultrasensitive biosensor for carcinoembryonic antigen (CEA) was constructed based on fluorescence resonance energy transfer (FRET) between upconverting nanoparticles (UCPs) and palladium nanoparticles (PdNPs). PdNPs was synthesized by the addition of a solution of Na2PdCl4 into a mixture of N2H4·H2O as the reducing agent and 11-mercaptoundecanoic acid (MUDA) as the stabilizer. The CEA aptamer (5'-NH2-ATACCAGCTTATTCAATT-3') was conjugated to hexanedioic acid (HDA) modified UCPs (HDA-UCPs) through an EDC-NHS coupling protocol. The coordination interaction between nitrogen functional groups of the CEA aptamer and PdNPs brought UCPs and PdNPs in close proximity, which resulted in the fluorescence quenching of UCPs to an extent of 85%. And the non-specific fluorescence quenching caused by PdNPs towards HDA-UCPs was negligible. After the introduction of CEA into the UCPs-CEA aptamer-PdNPs fluorescence quenching system, the CEA aptamer preferentially combined with CEA accompanied by the conformational change which weakened the coordination interaction between the CEA aptamer and PdNPs. So fluorescence recovery of UCPs was observed and a linear relationship between the fluorescence recovery of UCPs and the concentration of CEA was obtained in the range from 2pg/mL to 100pg/mL in the aqueous buffer with the detection limit of 0.8pg/mL. The ultrasensitive detection of CEA was also realized in diluted human serum with a linear range from 4pg/mL to 100pg/mL and a detection limit of 1.7pg/mL. This biosensor makes the most of the high quenching ability of PdNPs towards UCPs with negligible non-specific fluorescence quenching and has broad application prospects in biochemistry.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carcinoembryonic antigen; Fluorescence quenching ability; Fluorescence resonance energy transfer; Palladium nanoparticles; Upconverting nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 27476061     DOI: 10.1016/j.bios.2016.07.070

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  6 in total

Review 1.  Aptamer and nanomaterial based FRET biosensors: a review on recent advances (2014-2019).

Authors:  Zeki Semih Pehlivan; Milad Torabfam; Hasan Kurt; Cleva Ow-Yang; Niko Hildebrandt; Meral Yüce
Journal:  Mikrochim Acta       Date:  2019-07-24       Impact factor: 5.833

2.  A fluorometric aptamer nanoprobe for alpha-fetoprotein by exploiting the FRET between 5-carboxyfluorescein and palladium nanoparticles.

Authors:  Guiyin Li; Junxiang Zeng; Huiling Liu; Ping Ding; Jintao Liang; Xinmin Nie; Zhide Zhou
Journal:  Mikrochim Acta       Date:  2019-04-30       Impact factor: 5.833

3.  The quantum dot vs. organic dye conundrum for ratiometric FRET-based biosensors: which one would you chose?

Authors:  Chloé Grazon; Margaret Chern; Patrick Lally; R C Baer; Andy Fan; Sébastien Lecommandoux; Catherine Klapperich; Allison M Dennis; James E Galagan; Mark W Grinstaff
Journal:  Chem Sci       Date:  2022-05-04       Impact factor: 9.969

4.  Fast Affinity Induced Reaction Sensor Based on a Fluorogenic Click Reaction for Quick Detection of Protein Biomarkers.

Authors:  Jingxin Liu; Mohammed A A Abdullah; Liwei Yang; Jun Wang
Journal:  Anal Chem       Date:  2019-12-13       Impact factor: 6.986

5.  Palladium Nanoparticles-Based Fluorescence Resonance Energy Transfer Aptasensor for Highly Sensitive Detection of Aflatoxin M₁ in Milk.

Authors:  Hui Li; Daibin Yang; Peiwu Li; Qi Zhang; Wen Zhang; Xiaoxia Ding; Jin Mao; Jing Wu
Journal:  Toxins (Basel)       Date:  2017-10-13       Impact factor: 4.546

6.  A Quest for New Cancer Diagnosis, Prognosis and Prediction Biomarkers and Their Use in Biosensors Development.

Authors:  Eda G Ramirez-Valles; Alicia Rodríguez-Pulido; Marcelo Barraza-Salas; Isaac Martínez-Velis; Iván Meneses-Morales; Víctor M Ayala-García; Carlos A Alba-Fierro
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.